Michael Schomaker
Michael Schomaker
Home
Research
Software & Code
Teaching
Book
Contact
Light
Dark
Automatic
CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study
A. Grimsrud
,
M. Cornell
,
M. Schomaker
,
M. P. Fox
,
C. Orrell
,
H. Prozesky
,
K. Stinson
,
F. Tanser
,
M. Egger
,
L. Myer
January 2016
PDF
Cite
Type
Journal article
Publication
Journal of Epidemiology and Community Health
, 70(6): pp.549-55
HIV
loss to follow-up
Related
A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment
Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy
Anti-V3-Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2-Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency
Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention?
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies
Cite
×